Product Comparison
![]() |
![]() |
![]() |
![]() |
No Image |
|
---|---|---|---|---|---|
McKesson # | 1056776 | 957060 | 1019697 | 970780 | 1079612 |
Description | Tazarotene 0.1% Cream Tube 60 Gram | Tacrolimus 0.1% Ointment Tube 30 Gram | Hylatopic Plus™ Emollient Combination No. 53 Cream Jar 450 Gram | Elidel® Pimecrolimus 1% Cream Tube 60 Gram | Ceracade™ Emollient Combination No. 103 Emulsion Tube 270 Gram |
Manufacturer # | 51672137303 | 45802070000 | 69482021616 | 00187510102 | 69489051127 |
Brand | Hylatopic Plus™ | Elidel® | Ceracade™ | ||
Manufacturer | Taro | Perrigo Company | Encore Dermatology | Valeant Pharmaceuticals | Journey Medical |
Invoice | TAZAROTENE, CRM 0.1% 60GM RX | TACROLIMUS, OINT 0.1% 30GM (1/EA) | HYLATOPIC PLUS, CRM 450GM (1/EA) | ELIDEL, CRM 1% 60GM (1/EA) | CERACADE SKIN BARRIER, EMUL 270GM (1/EA) |
Log In to Order | Log In to Order | Log In to Order | Log In to Order | Log In to Order | |
Comparison |
|||||
Alternate Manufacturer Number | 3625407 | 3280476 | 3940830 | 2189660 | 3632627 |
Container Type | Tube | Tube | Jar | Tube | Tube |
Dosage Form | Cream | Ointment | Cream | Cream | Emulsion |
Generic Drug Code | 85363 | 12302 | 30324 | 15348 | 41466 |
Generic Drug Name | Tazarotene | Tacrolimus | Emollient Combination No. 53 | Pimecrolimus | Emollient Combination No. 103 |
NDC Number | 51672137303 | 45802070000 | 69482021616 | 00187510102 | 69489051127 |
Strength | 0.1% | 0.1% | 1% | ||
UNSPSC Code | 51241219 | 51202804 | 51241900 | 51202801 | 51241900 |
Volume | 60 Gram | 30 Gram | 450 Gram | 60 Gram | 270 Gram |
Application | Dermatological Agent | Dermatological Agent | Dermatological Agent | Dermatological Agent | Dermatological Agent |
Country of Origin | Unknown | Unknown | Unknown | Unknown | Unknown |
Product Dating | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days |
Type | Topical | Topical | Topical | Topical | Topical |
Features and Benefits |
|
|
|
|
|